Dermatology Medicine Market Analysis and Reports | UK Conference Series

Market Analysis - Dermatology Medicine 2020

ConferenceSeries LLC Ltd welcomes you to join 15th International Conference on Dermatology and Cosmetic Medicine scheduled at April 13- 14, 2019 London, UK.

Importance & Scope of Dermatology in Global Health:

Skin disease is one of the main sources of non-lethal ailment load comprehensively, influencing a large number of individuals. Aging, trauma, and environmental and genetic factors can result in the advancement of skin diseases. As indicated by the World Health Organization (WHO), skin diseases are among the most widely recognized human wellbeing issue and influence very nearly 900 million individuals over the world at some random time. The absolute most regular sorts of skin infections detailed all around are pyoderma, scabies, acne, dermatitis, and moles. Acne is the most widely recognized skin condition in the U.S., influencing up to 50 million Americans every year. The treatment costs for skin inflammation in the nation surpassed $1.2 billion of every 2013. Various medications, including dermatology drugs, are accessible these days to avoid the event of dermatological diseases. Along these lines, the expanding occurrence of skin illnesses is bringing about the intense interest for dermatological medications, which, thusly, is driving the dermatology drugs dermatology drugs market growth. 

 

According to the American Society of Plastic Surgeons (ASPS), almost 18 million people underwent surgical and minimally invasive cosmetic procedures in the United States in 2018. Cosmetic surgery focuses on body enhancement, while plastic surgery reconstructs body parts that have sustained damage due to disease, burns, or trauma.

The authors of an earlier study in the United Kingdom analyzed 204 questionnaires to identify the factors that drive people to undergo cosmetic surgery. The findings showed that women who rated their self-esteem, life satisfaction, and attractiveness as low, had few religious beliefs, and had high media exposure were more likely to undergo cosmetic surgery.

Top 5 cosmetic surgical procedures in 2018:

  • Breast augmentation — 313,735 procedures.
  • Liposuction — 258,558 procedures.
  • Nose reshaping — 213,780 procedures.
  • Eyelid surgery — 206,529 procedures.
  • Tummy tuck — 130,081 procedures.

Dermatology Drugs Market Competitive Landscape:

Different dermatological medications manufactured by key players are being endorsed by the administrative specialists, for example, the U.S. Food and Drug Administration (USFDA) and the European Union (EU), which, thus, is decidedly influencing the development of the dermatology drugs showcase. For example, in November 2018, the USFDA allowed the need audit for Sanofi's supplemental Biologics License Application (sBLA) for Dupixent (dupilumab) as potential treatment for immature patients (matured 12– 17 years) with uncontrolled moderate-to-extreme atopic dermatitis.

Essentially, in September 2018, Sanofi got the USFDA endorsement for its Libtayo (cemiplimab-rwlc) for the treatment of patients with metastatic cutaneous squamous cell carcinoma (CSCC) or privately progressed CSCC who are not possibility for corrective medical procedure or healing radiation.

A portion of the other key players working in the worldwide dermatology drugs industry are Celgene Corporation, Bausch Health Companies Inc., Novartis AG, Pfizer Inc., Bristol-Myers Squibb Company, Johnson and Johnson, Allergan plc, Merck and Co. Inc., Amgen Inc., AbbVie Inc., Eli Lilly and Company, Nestlé Skin Health S.A., GlaxoSmithKline plc, Mylan N.V., and LEO Pharma A/S.

As per the statistical surveying report distributed by P&S Intelligence, Dermatology drugs showcase is relied upon to reach $34.5 billion by 2023. Based on treatment, the dermatology drugs showcase has been ordered into topical corticosteroids, retinoids, biologics, calcineurin inhibitors, antihistamines, hormonal treatment, and others. Among these, biologics is relied upon to be the quickest developing classification, progressing at CAGR of 9.1% amid the gauge time frame.

Organizations working in the dermatology drugs advertise are teaming up with other pharmaceutical firms to grow new and creative items. For example, in November 2018, Sanofi worked together with Denali Therapeutics Inc. (Denali), a biopharmaceutical organization, for the improvement of different particles, DNL747 and DNL758, with the possibility to treat a scope of neurological and foundational incendiary ailments. Under the understanding, Sanofi will pay $125 million to Denali to think about the lead particle DNL747 in numerous sclerosis, Alzheimer's sickness, and amyotrophic horizontal sclerosis and DNL758 in fundamental fiery illnesses, for example, rheumatoid joint inflammation and psoriasis.

Why London?

London is the capital and largest city of both England and the United Kingdom. London is considered to be one of the world's most important global cities and has been termed the world's most powerful, most desirable, most influential, most visited, most expensive, innovative, sustainable, most investment friendly, most popular for work, and the most vegetarian friendly city in the world. London exerts a considerable impact upon the arts, commerce, education, entertainment, fashion, finance, healthcare, media, professional services, research and development, tourism and transportation.

London is a major global centre of higher education teaching and research and has the largest concentration of higher education institutes in Europe. According to the QS World University Rankings 2015/16, London has the greatest concentration of top class universities in the world and its international student population of around 110,000 is larger than any other city in the world.

London is home to five major medical schools – Barts and The London School of Medicine and Dentistry (part of Queen Mary), King's College London School of Medicine (the largest medical school in Europe), Imperial College School of Medicine, UCL Medical School and St George's, University of London – and has a large number of affiliated teaching hospitals. It is also a major centre for biomedical research, and three of the UK's eight academic health science centres are based in the city – Imperial College Healthcare, King's Health Partners and UCL Partners (the largest such centre in Europe).

London Tourist Attractions:

London is one of the leading tourist destinations in the world with over 65 million visits. Tourism is one of London's prime industries, employing the equivalent of 350,000 full-time workers in 2003, and the city accounts for 54% of all inbound visitor spending in the UK. London contains four World Heritage Sites: the Tower of London; Kew Gardens; the site comprising the Palace of Westminster, Westminster Abbey, and St Margaret's Church; and the historic settlement in Greenwich where the Royal Observatory, Greenwich defines the Prime Meridian, 0° longitude, and Greenwich Mean Time. Other landmarks include Buckingham Palace, the London Eye, Piccadilly Circus, St Paul's Cathedral, Tower Bridge, Trafalgar Square and The Shard. London has numerous museums, galleries, libraries and sporting events. These include the British Museum, National Gallery, Natural History Museum, Tate Modern, British Library and West End theatres. The London Underground is the oldest underground railway network in the world.

Major Dermatology Associations in London:

Major Dermatology Associations in UK:

Major Dermatology Associations around the Globe:

Top Dermatology Universities in London:

Top Dermatology Universities in UK:

Top Dermatology Universities around the Globe:

Hospitals Associated with Dermatology Research in London:

Hospitals Associated with Dermatology Research in UK:

Hospitals Associated with Dermatology Research around the Globe: